laura jonaus schumacher  spring lake mi  intelius sign in we found laura jonaus schumacher in spring lake mi laura jonaus schumacher intelius found that laura jonaus schumacher is a female between  and  years old from spring lake mi we have connected them to  addresses  phones and  relatives or associates also known as laura a schumacher laura jonaus jonaus get report now age laura jonaus schumacher is in her s laura has lived in spring lake mi chicago il brookfield wi lauras relatives joline jonaus lawrence jonaus jane schumacher laura jonaus schumacher zodiac signgemini genderfemale get report now want to know more about laura get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about laura or use our people search engine to find others get background check on laura jonaus schumacher get a criminal check on laura jonaus schumacher get a public record report on laura jonaus schumacher get a people search report on laura jonaus schumacher laura jonaus schumachers contact information known cities lived in find out where laura jonaus schumacher has lived as well as laura jonaus schumachers phone numbers and email addresses laura jonaus schumacher has lived in  states michigan address for laura jonaus schumacher  n s d spring lake mi has lived in spring lake mi chicago il get full address report phone numbers associated with laura jonaus schumacher    spring lake mi    spring lake mi    lake bluff il get full phone report email addresses associated with laura jonaus schumacher rgnet get email report laura jonaus schumachers social network and potential email matches find out potential social network profiles and potential email usernamed for laura jonaus schumacher laura jonaus schumachers known social networks and potential email matches find all of laura jonaus schumachers social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches laura schumacher username matches lauraschumacher schumacherlaura lauraschumacher schumacherlaura lauraschumacher schumacherlaura lauraschumacher schumacherlaura lschumacher popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches l schumacher intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here laura j schumacher of abbvie inc executive profile   welcome company news company site premium log in membership home portfolio stocks bonds funds etfs cef markets tools real life finance discuss investing ideas fund analyst picks picks by category fund pick performance picks  pans enewsletter fund spy column fund spy book bond squad fund video reports fundinvestor newsletter etf investing fund family experts fund reports all fund analyst reports fund stewardship reports fund ratings highestrated value highestrated growth highestrated largecap highestrated midcap highestrated smallcap foreign fund standouts star rating performance rating methodology fund performance top month performers top ytd performers top year performers top year performers top year performers fund category returns biggest daily nav changes closedend funds exchangetraded funds quarterly market outlook fund screeners basic screeners fund screener longterm winners solid smallgrowth funds conservative bond funds premium screeners premium fund screener index funds hidden gems lowerrisk foreign funds video center abbvie inc  abbv add to portfolioget email alertsprint this pagepdf reportdata questionquotechartstock analysisperformancekey ratiosfinancialsvaluationinsidersownershipfilingsbondsoverviewexecutive compensationinsider activitykey executivesboard of directorscommittees key executives  laura j schumacher laura j schumacher executive vice president external affairs general counsel and secretary profile connections biography ms schumacher is abbvies executive vice president external affairs general counsel and corporate secretary responsible for abbvies externallyfacing functions of health economics outcomes research government affairs corporate responsibility brand and communications she also leads all legal functions and biotherapeutics strategy prior to abbvies separation from abbott ms schumacher served as executive vice president general counsel and corporate secretary from  to  and as senior vice president corporate secretary and general counsel from  to  both at abbott and abbvie ms schumacher also led licensing and acquisition and ventures and early stage collaborations at abbott ms schumacher was also responsible for its office of ethics and compliance ms schumacher joined abbott in  she serves on the board of general dynamics corporation board membership company name board member since board committees laura j schumacher is connected to  board memberssee list of all board connections   we value your feedback let us know what you think site directory site map our products corrections help advertising opportunities licensing opportunities glossary rss mobile portfolio affiliate careers international sites australia canada china france germany hong kong italy the netherlands norway spain uk switzerland stocks by name  ticker  star rating  market cap  stock type  sector  industry mutual funds by star rating  investment style  total assets  category  top holdings  top sectors  symbol  ticker  name etfs by star rating  category  total assets  symbol  ticker  name articles by title  date  author  collection  interest  popularity investment categories by topic  sector  key indicators  user interest  market cap  industry premium stocks by name  ticker  star rating  market cap  stock type  sector  industry premium mutual funds by star rating  investment style  total assets  category  top holdings  top sectors  symbol  ticker  name premium etfs by star rating  category  total assets  symbol  ticker  name popular articles by title  date  author  collection  interest  popularity popular investment categories by topic  sector  key indicators  user interest  market cap  industry independent insightful trusted morningstar provides stock market analysis equity mutual fund and etf research ratings and picks portfolio tools and option hedge fund ira k and  plan research our reliable data and analysis can help both experienced enthusiasts and newcomers  copyright morningstar inc all rights reserved please read our terms of useand privacy policydow jones industrial average sp  nasdaq and morningstar index market barometer quotes are realtime russell  quote is  minutes delayed laura j schumacher executive vice president business development external affairs and general counsel abbvie timesjavascript is disabled market profiles login sign up login sign up   edit person laura j schumacher executive vice president business development external affairs and general counsel at abbvie location add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop laura j schumacher executive vice president business development external affairs and general counsel at abbvie location add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop laura schumacher is executive vice president business development external affairs and general counsel responsible for abbvie’s legal licensing and acquisitions government affairs health economics outcomes research investor relations and public affairs functions prior to abbvie’s separation from abbott ms schumacher served as executive vice president general counsel and secretary and had additional responsibilities for licensing and acquisitions as well as the office of ethics and compliance  companies in career na related markets  colleagues na related investments alias na industry pharmaceuticals tags pharmaceuticals topics of influence na na careers achievements investments related people edit view all laura j schumachercareer  abbvie executive vice president business development external affairs and general counsel  abbott laboratories executive vice president mar to  abbott laboratories general counsel  to feb abbott laboratories vice president and deputy general counsel  to  abbott laboratories secretary competencies edit view all laura j schumachereducation   university of wisconsin  madison  university of notre dame edit laura j schumacherachievements and recognitions add milestone no milestones has been recorded for laura j schumacher edit laura j schumacherlinks add link no links has been recorded for laura j schumacher laura j schumacherinvestmentsacquisitions no investments has been recorded for laura j schumacher laura j schumacherinvestments representing others no investment reps has been recorded for laura j schumacher laura j schumacherrelated people colleagues at abbvie william j chase executive vice president chief financial officer richard a gonzalez chairman chief executive officer and chairman of executive committee richard a gonzalez chief operating officer and director view all laura j schumacherrecommended market profiles  telemedicine  or more employees  companies social media marketing chiefmarteccom    employees  companies big data universe list of lists  or more employees  companies aggregated marketing technology  or more employees  companies shared economy landscape jeremiah owyang  or more employees  companies inside sales landscape  or more employees  companies laura j schumacher  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in laura j schumacher secretary general counsel and executive vice president business development and external affairs at abbvie view full profile are you laura j schumacher claim your profile   sign up for equilar atlas and view laura j schumachers full profile with equilar atlas you can identify corporate executives in laura j schumachers network and community follow changes in laura j schumachers employment and moneyinmotion connect with laura j schumacher through your network of contacts laura j schumachers executive work history current secretary general counsel and executive vice president business development and external affairs abbvie board member general dynamics corporation past to view laura j schumachers complete executive work history sign up now education jd university of wisconsin bachelors university of notre dame age      laura j schumachers biography executive vice president external affairs and general counsel of abbvie inc since january  executive vice president general counsel and secretary of abbott laboratories  to  key attributesskillsexpertise ms schumachers positions as chief legal officer of two large public companies provide her with extensive experience with respect to risk management and a deep knowledge of the types of legal and regulatory risks facing public companies her experience as a senior executive in the healthcare industry has provided her with a keen awareness of strategic considerations and challenges associated with a complex highlyr  read more executive vice president external affairs and general counsel of abbvie inc since january  executive vice president general counsel and secretary of abbott laboratories  to  key attributesskillsexpertise ms schumachers positions as chief legal officer of two large public companies provide her with extensive experience with respect to risk management and a deep knowledge of the types of legal and regulatory risks facing public companies her experience as a senior executive in the healthcare industry has provided her with a keen awareness of strategic considerations and challenges associated with a complex highlyregulated industry additionally through her key role in the strategic consideration and execution of the separation of abbvie from abbott laboratories ms schumacher brings an important understanding of and insight into corporate governance matters and complex corporate transactions source general dynamics corporation on    sign up for equilar atlas and view laura j schumachers full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like laura j schumacher more specifically youll be able to identify corporate executives in laura j schumachers network and community follow changes in laura j schumachers employment and moneyinmotion connect with laura j schumacher through your network of conections view full profile   search for over  executive profiles bio example laura j schumacher laura j schumachers connections  sign up now to view laura j schumachers  connections » paul j hastings chairman of the board chief executive officer and president oncomed pharmaceuticals inc william a osborn board member caterpillar inc edward m liddy board member m company nancy mckinstry board member abbott laboratories steven j mento dir president chief executive officer and acting principal financial officer conatus pharmaceuticals inc michael severino former executive vice president research and development and chief scientific officer abbvie phebe n novakovic chairman and chief executive officer general dynamics corporation thomas c freyman board member tenneco inc roxanne s austin board member abbott laboratories kleanthis g xanthopoulos board member apricus biosciences inc popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith elon r musk ceo and chairman tesla daniel a dematteo executive chairman gamestop corp david j oconnor president and ceo the madison square garden company × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login �  equilar all rights reserved privacy policy  marshall street redwood city ca   phone    fax   insider trading  schumacher laura j  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  schumacher laura j select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in common stock purchase or sale transactiondate reporteddate company symbol insiderrelationship sharestraded averageprice totalamount sharesowned filing sale  pm abbvie inc abbv schumacher laura jexecutive vice president    direct view sale  pm abbvie inc abbv schumacher laura jexecutive vice president    direct view sale  pm abbvie inc abbv schumacher laura jexecutive vice president    direct view sale  pm abbvie inc abbv schumacher laura jevp busdevextaffgc    direct view stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing option award  pm nana general dynamics corp gd schumacher laura jdirector   direct view gift  pm nana abbvie inc abbv schumacher laura jexecutive vice president   direct view option award  pm nana general dynamics corp gd schumacher laura jdirector   direct view exercise  pm nana abbvie inc abbv schumacher laura jexecutive vice president   direct view exercise  pm nana abbvie inc abbv schumacher laura jexecutive vice president   direct view exercise  pm nana abbvie inc abbv schumacher laura jexecutive vice president   direct view exercise  pm nana abbvie inc abbv schumacher laura jexecutive vice president   direct view exercise  pm  abbvie inc abbv schumacher laura jexecutive vice president   direct view exercise  pm  abbvie inc abbv schumacher laura jexecutive vice president   direct view exercise  pm  abbvie inc abbv schumacher laura jexecutive vice president   direct view exercise  pm  abbvie inc abbv schumacher laura jexecutive vice president   direct view option award  pm nana general dynamics corp gd schumacher laura jdirector   direct view option award  pm nana general dynamics corp gd schumacher laura jdirector   direct view option award  pm nana general dynamics corp gd schumacher laura jdirector   direct view option award  pm na general dynamics corp gd schumacher laura jdirector   direct view tax withholding  pm nana abbvie inc abbv schumacher laura jexecutive vice president   direct view option award  pm  abbvie inc abbv schumacher laura jexecutive vice president   direct view gift  pm nana abbvie inc abbv schumacher laura jexecutive vice president   direct view option award  pm nana general dynamics corp gd schumacher laura jdirector   direct view option award  pm nana general dynamics corp gd schumacher laura jdirector   direct view option award  pm nana general dynamics corp gd schumacher laura jdirector   direct view option award  pm nana general dynamics corp gd schumacher laura jdirector   direct view option award  pm nana general dynamics corp gd schumacher laura jdirector   direct view option award  pm na general dynamics corp gd schumacher laura jdirector   direct view tax withholding  pm nana abbvie inc abbv schumacher laura jevp busdevextaffgc   direct view tax withholding  pm nana abbvie inc abbv schumacher laura jevp busdevextaffgc   direct view option award  pm nana abbvie inc abbv schumacher laura jevp busdevextaffgc   direct view option award  pm  abbvie inc abbv schumacher laura jevp busdevextaffgc   direct view   secformcom all rights reserved archives        mon  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  laura j schumacher  jacksonville nc  intelius sign in we found laura j schumacher in jacksonville nc laura j schumacher intelius found that laura j schumacher is a female between  and  years old from jacksonville nc we have connected them to  addresses  phones and  relatives or associates get report now age laura j schumacher is in her s laura has lived in jacksonville nc millington tn camp lejeune nc lauras relatives karen hasbargen randall schumacher laura j schumacher zodiac signaquarius genderfemale get report now want to know more about laura get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about laura or use our people search engine to find others get background check on laura j schumacher get a criminal check on laura j schumacher get a public record report on laura j schumacher get a people search report on laura j schumacher laura j schumachers contact information known cities lived in find out where laura j schumacher has lived as well as laura j schumachers phone numbers and email addresses laura j schumacher has lived in  states north carolina address for laura j schumacher d j c jacksonville nc has lived in jacksonville nc millington tn get full address report phone numbers associated with laura j schumacher    jacksonville nc    jacksonville nc    jacksonville nc get full phone report email addresses associated with laura j schumacher get email report laura j schumachers social network and potential email matches find out potential social network profiles and potential email usernamed for laura j schumacher laura j schumachers known social networks and potential email matches find all of laura j schumachers social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches laura schumacher username matches lauraschumacher schumacherlaura lauraschumacher schumacherlaura lauraschumacher schumacherlaura lauraschumacher schumacherlaura lschumacher popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches l schumacher intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here executive vp at abbvie tops gen list as highest paid woman in biopharma  gen genetic engineering  biotechnology news human neural stem cell therapy for chronic ischemic stroke gen quiz evaluate your knowledge on cancer obesity and crispr movies is calcium the achilles heel for clostridium infections cannabidiol does not convert to thc in vivo literature review organsonchips marching in hcv drug therapy and the dna base excision repair system reducing the need for clinical bioequivalence endpoint studies the prodrug opportunity making good drugs better exclusives looking at the cart landscape as first  human neural stem cell therapy for chronic ischemic stroke gen quiz evaluate your knowledge on cancer obesity and crispr movies is calcium the achilles heel for clostridium infections cannabidiol does not convert to thc in vivo literature review organsonchips marching in hcv drug therapy and the dna base excision repair system reducing the need for clinical bioequivalence endpoint studies the prodrug opportunity making good drugs better news adding cox inhibition to checkpoint in pain management may benefit from “outside the cell” thinking about phosphorylation brainstorm wins m cirm grant for phase iii trial of als cell therapy novel strategy targets cancer cells while sparing normal ones fda to review bla for amgennovartis migraine prevention treatment gene drives will need a tuneup to power past resistance alligator aptevo partner on bispecific cancer immunotherapy targeting bb merck wins tentative fda approval for lusduna crispr structure data reveal how cas enzymes choose target the lists top  immunooncology collaborations  biotech and biopharma recruiters  clinical failures of q  the top  bestselling drugs of  top  under  top eight asia biopharma clusters  top  us biopharma clusters top  european biopharma clusters  takeover targets for  magazine optimizing the delivery of peptidebased insights gene therapy a new twist on an old helix short stories to peruse—with info you might use panasonic launches new dualcompressor freezers gen roundup top trends in tissue engineering advancing d cell culture for biomedical research using primary cells accelerating novel therapeutic discovery manufacturing of aav vectors for gene therapy current issue » past issues » more gen polls best apps webinars podcasts ebooks events subscribe to gen best of the web bioperspectives video new products subscribe gen select loginregister leading the way in life science technologies facebook twitter linkedin youtube google rss gen exclusives more » hcv drug therapy and the dna base excision repair system the influence of new antihcv therapy on the dna base excision repair system of peripheral blood mononuclear cells the prodrug opportunity making good drugs better elegance in chemistry product development and marketability infographic spotlight on how a discovery program was born looking at the cart landscape as first approval nears sounds of science podcast press releases more » august   executive vp at abbvie tops gen list as highest paid woman in biopharma new rochelle ny august  —laura j schumacher an executive vp at abbvie nyseabbv topped “the gen list of the  top paid women executives in biopharma” schumacher who oversees business development and external affairs at the company and serves as general counsel had a total compensation package of  in  coming in second was beatrice cazala executive vp of commercial operations at bristolmyers squibb nysebmy with a total  compensation of  according to gen “our listing clearly shows that women have breached the pharma industry’s glass ceiling” says john sterling editor in chief of gen “but they still have a way to go before they catch up with many of their male colleagues our recent listing of the total compensation that the top  biopharma ceos were receiving all males highlighted this issue for example numbers one and two on that list were leonard schleifer of regeneron nasdaqregn with  in  and william weldon formerly of johnson  johnson nysejj with a tally of  the number   and  positions on the gen executive women in biopharma listing were filled by heather bresch ceo of mylan nasdaqmyl  martine rothblatt ceo of united therapeutics nasdaquthr  and sandra leung general counsel and corporate secretary at bristolmyers squibb  as with the previously mentioned ceo compensation rankings this list shows the continuing leveling of the industry between traditional “big” pharma and biotech six of the top  women executives on this list work at pharmas the rest at biotechs however positions – on the list were filled entirely by biotech executives in addition of the  women on this list  held positions at the executive or senior vice presidential level and seven of those had responsibilities that included that of general counsel one woman was a chief medical officer and another a chief commercial officer to see the entire gen list of the  top paid women executives in biopharma please go here for immediate release contact john sterling editor in chiefgenetic engineering  biotechnology news  email protected genetic engineering  biotechnology news which is published  times a year by mary ann liebert inc is the most widely read biotechnology news magazine worldwide it includes articles on drug discovery bioprocessing omics biobusiness and translational medicine ×  vote get results more » congratulations you are now a gen select insider you now have access to indepth reports peer reviewed papers and hot jobs   genetic engineering  biotechnology news all rights reserved gen about gen press releases reprints  permissions contact gen gen editorial editorial staff editorial guidelines  planning calendar advertise gen media kit classified media kit ad terms  conditions gen list rental subscription center gen magazine enewsletters resources app notes biotech boulevard clinical omics new products podcasts home  terms of use  privacy statement  legal  mary ann liebert inc form  abbvie inc for feb  filed by schumacher laura j research stocks news story skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  news  events  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print format change text size default text sizea larger text sizea largest text sizea form  abbvie inc for feb  filed by schumacher laura j by k wizard—  pm et  httparchivefastedgarcomaozurczwzgzzhmbzzrx filed on march   more abbv news abbv has no more news copyright – fmr llc  all rights reserved  terms of use privacy security site map  stock market research top stocks quotes  news  fidelity investments skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window stock research  ideas you are here stock research center my research screen  filter stock screeners preset expert strategies news  insights events calendar upgrades  downgrades explore firm research research firms research firm scorecards reports search related resources fidelity learning center us markets global markets sectors  industries stock research center not a fidelity customer no problem try our research for free without opening an account   trending stocks market movers top rated by sector orders by fidelity customers filters refresh equity summary score provided by starmine investing insights technical events provided by recognia as of  methodology recognia methodology bullish and bearish events of the day provide longshort trading ideas by identifying us stocks that have recently formed a bullish or bearish classic chart pattern patterns must have taken at least  days to form which draws out the more significant patterns for intermediate or longterm trend direction the list is then filtered to include stocks with a minimum  for bullish and  for bearish close price and a minimum  trading volume most recent patterns are listed first patterns on the same date are sorted using recognias proprietary quantitative algorithm to draw strong companies to the top and if further sorting is required for stocks with the same quantitative analysis result it is done by trading volume to draw highest volume stocks to the top bofi log in for events hafc an earn epam sn log in for events chkp lho fit gts find out how to use fundamental analysis and technical analysis when evaluating stocks with the help of the fidelity learning center my research –  organize and track your favorite securities get started todays events as of  am et  earnings  dividends  splits  upgrades  downgrades  economic  upcoming webinar events visit the learning center events page for a full list of upcoming webinars the equity summary score is provided for informational purposes only does not constitute advice or guidance and is not an endorsement or recommendation for any particular security or trading strategy the equity summary score is provided by thomson reuters starmine an independent company not affiliated with fidelity investmentsgics® global industry classification standards is an industry classification system developed by standard  poors in collaboration with morgan stanley capital international msci sp uses gics to determine the market segment to which a company is assignednews commentary including related symbols and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their usestock markets especially foreign markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments sector funds can be more volatile because of their narrow concentration in a specific industrysystem availability and response times may be subject to market conditionsthe fidelity screeners are research tools provided to help selfdirected investors evaluate securities the criteria and inputs entered are at the sole discretion of the user and all screens or strategies with preselected criteria are solely for the convenience of the user information supplied or obtained from the screeners is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell securities or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy or approach to screening or evaluating stocks preferred securities exchange traded products or closed end funds fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their use determine which securities are right for you based on your investment objectives risk tolerance financial situation and other individual factors and reevaluate them on a periodic basis copyright – fmr llc  all rights reserved  terms of use privacy security site map  abbv stock news  fidelity skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print  helpglossary helpglossary news  eventsabbv abbvie inc    as of pm et  quotes delayed at least  min log in for real time quote add to watch list set alert hypothetical trade option chain price history download to csv file download to excel file log in for more news expand all collapse all abbvie receives chmp positive opinion for humira® adalimumab for the treatment of pediatric patients with chronic noninfectious anterior uveitis pr newswire –  am et  north chicago ill todays positive chmp opinion marks a significant milestone for pediatric uveitis patients and their caregivers said marek honczarenko vice president immunology development uveitis is an inflammation of the uvea which includes the iris choroid and the ciliary body in the eye gaza health care suffers as palestinian factions play blame game reuters –  am et   hamaspalestinian authority dispute at root of crisis  gaza hospitals short on power medicine  cystic fibrosis patients in gaza especially at risk by nidal almughrabi ritta aljalees doesnt care whos to blame for the deteriorating state of healthcare in gaza novartis stocks drug cabinet with big arthritis blockbusters reuters –  am et   novartis hawks cutrate arthritis drug copies  hopes broad offering gives it boost over rivals  biosimilars key piece of novartis  growth plan by john miller switzerlands novartis is stocking up cheaper versions of the worlds topselling arthritis medicines hoping a broad portfolio gives it an edge on rivals with narrower offerings abbvie to host secondquarter  earnings conference call pr newswire –  am et  north chicago ill abbvie abbv will host a live webcast of the earnings conference call at  am central time it will be accessible through abbvies investor relations website investorsabbviecom an archived edition of the session will be available later that day briefcytomx achieves development milestone in collaboration with abbvie reuters –  am et  cytomx therapeutics inc ctmx  cytomx achieves development milestone in strategic oncology collaboration with abbvie abbv for cdtargeting probody drug conjugate  cytomx therapeutics inc ctmx  will receive a  million milestone payment from abbvie abbv as part of  strategic oncology collaboration between companies source text for eikon further company coverage breakfast technical briefing on drug makers stocks  pfizer merck abbvie and johnson  johnson pr newswire –  am et  new york june   if you want a stock review on pfe mrk abbv or jnj then come over to httpdailystocktrackercomregister and sign up for your free customized report today httpdailystocktrackercomregister pfizer  new york headquartered pfizer incs pfe stock rose  finishing last fridays trading session at  a total volume of  million shares was traded which w abbvie receives chmp positive opinion for maviret™ glecaprevirpibrentasvir for the treatment of chronic hepatitis c in all major genotypes gt pr newswire –  am et  north chicago ill maviret represents a new generation of hcv therapy and has the potential to be a shorter week option for patients living with this serious chronic illness said michael severino md executive vice president research and development and chief scientific officer abbvie briefeu medicines agency recommends approval of aveos kidney cancer drug reuters –  am et  eu medicines agency  eu medicines agency recommendations for june   eu medicines agency recommends approval of merck kgaa multiple sclerosis drug  eu medicines agency recommends approval of abbvie abbv hepatitis c combination  eu medicines agency recommends approval of novartis kisqali drug for breast cancer  eu medicines agency recommends approval of aveo drug for kidney cancer eu backs second biosimilar copy of humira worlds top drug reuters –  am et  european regulators have recommended approval of a second copy of abbvies abbv rheumatoid arthritis drug humira the worlds topselling medicine in a further boost for socalled biosimilars in the region samsung makes big play in drug market with cheaper version of blockbuster humira dj business news –  am et  by timothy w martin in seoul and jonathan d rockoff in new york a samsung group arm is on track to win european regulatory approval for a nearreplica version of the worlds top selling drug abbvie inc s rheumatoidarthritis treatment humira the latest achievement by the deeppocketed south korean conglomerate attempting to shake up the pharmaceutical market samsung bioepis co the groups new biotechnology company said in a statement friday that it had received a briefema recommends approval of mercks multiple sclerosis drug reuters –  am et  eu medicines agency  eu medicines agency recommendations for june   eu medicines agency recommends approval of merck kgaa multiple sclerosis drug  eu medicines agency recommends approval of abbvie hepatitis c combination  eu medicines agency recommends approval of novartis kisqali drug for breast cancer  eu medicines agency recommends approval of aveo drug for kidney cancer briefabbvie sets quarterly cash dividend of  per share reuters –  pm et  abbvie inc abbv  sets quarterly cash dividend of  per share  abbvie inc abbv says declared a quarterly cash dividend of  per share source text for eikon further company coverage abbvie declares quarterly dividend pr newswire –  pm et  north chicago ill the cash dividend is payable aug   to stockholders of record at the close of business on july   since the companys inception in  abbvie abbv has increased its dividend by  percent briefabbvie and principia to collaborate on oral immunoproteasome inhibitors reuters –  am et  abbvie inc abbv  abbvie abbv and principia announce collaboration on oral immunoproteasome inhibitors  financial terms were not disclosed  abbvie abbv  upon successful completion co will be responsible for ongoing clinical development and commercialization of viable compounds resulting from partnership abbvie and principia announce collaboration on oral immunoproteasome inhibitors pr newswire –  am et  north chicago ill and south san francisco calif principia has discovered a novel technology that has the potential to enhance the treatment landscape for a variety of immunological diseases said lisa olson vice president immunology research abbvie abbvie must pay  mln in depakote birthdefect trial jury reuters –  pm et  a federal jury on friday awarded  million to a yearold boy whose mother blamed his birth defect on abbvie incs abbv bipolar disorder drug depakote that she took while pregnant in the latest trial among hundreds of lawsuits over the product jurors in federal court in east st louis illinois awarded the compensatory damages to stevie gonzalez who was born with spina bifida abbvie suffers  million loss in depakote birthdefect trial reuters –  pm et  a federal jury on friday awarded  million to a california woman who blamed her sons birth defects on abbvie incs abbv bipolar disorder drug depakote in the latest trial to spill out of hundreds of lawsuits over the drug abbvies rheumatoid arthritis drug succeeds in trial reuters –  pm et   upadacitinib a jak inhibitor more effective than a placebo  fda had rejected a rival jak inhibitor drug  months back  drug could help lower abbvies abbv reliance on humira  abbvie abbv shares rise as much as  pct to month high by divya grover briefsynlogic says has completed st phase of abbvie collaboration reuters –  am et  synlogic  synlogic says has completed first phase of its ongoing collaboration with abbvie abbv  synlogic  during first discovery phase synlogic identified synthetic biotic leads for treatment of inflammatory bowel disease including crohns disease colitis abbvies rheumatoid arthritis drug succeeds in latestage trial reuters –  am et  us drugmaker abbvie inc abbv said on wednesday its drug to treat moderatetosevere rheumatoid arthritis met the main goal in a latestage study two doses of the drug upadacitinib were compared against a placebo in the week long study abbvie abbv said page page   next  todays and upcoming events jul  abbv to announce q earnings before market confirmed jul  abbv earnings conference call at  am listen past events last  days jul  abbv exdividend for  on  announce date  record date  pay date  data provided by wall street horizon inc   technical events classic patterns past  days provided by recognia inc log in for trading events view all technical analysis in advanced chart technical analysis provided by trading central log in for trading events as with all your investments through fidelity you must make your own determination whether an investment is appropriate for you fidelity is not recommending or endorsing this security by making it available to customers you should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase before investing you should read the prospectus offering circular indenture or similar document carefully for a full description of the product including its features and risks to determine whether it is an appropriate investment for your investment objectives risk tolerance financial situation and other individual factors and be sure to reevaluate those factors on a periodic basisperformance data shown represents past performance which is no guarantee of future results current performance may be higher or lower than the performance data quoted yield and return will vary therefore you may have a gain or loss when you sell your sharesstock markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments growth stocks can be more volatile than other types of stocks value stocks can continue to be undervalued by the market for long periods of time foreign securities are subject to interestrate currencyexchangerate economic and political risks all of which are magnified in emerging markets illiquidity is an inherent risk associated with investing in real estate and reits there is no guarantee the issuer of a reit will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid closedend funds can trade at a discount to their nav shareholders of master limited partnerships may be treated as partners for tax purposes partnerships issue a schedule k form  rather than a form  form for tax purposes it lists the partners share of income deductions credits etc speak with your tax advisor to determine how this may affect you a royalty trust is a type of corporation mostly in the united states or canada usually involved in oil and gas production or mining royalty trusts may have special tax treatment so you should consult a tax advisor on the potential tax consequences of investing in themnews commentary and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their useany data charts and other information provided on this page are intended for research purposes to help selfdirected investors evaluate many types of securities including but not limited to common stocks american depository receipts master limited partnerships real estate investment trusts traditional preferred stock trust preferred securities thirdparty trust certificates convertible securities mandatory convertible securities and other exchangetraded equity andor debt securities criteria and inputs entered including the choice to make security comparisons are at the sole discretion of the user and are solely for the convenience of the user analyst opinions ratings and reports are provided by thirdparties unaffiliated with fidelity all information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell a security or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy any analyst opinionratingreport or any approach to evaluating individual securities fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from its use copyright – fmr llc  all rights reserved  terms of use privacy security site map  see the latest features personalizedget relevant information about your holdings right when you need itsee your performance click the portfolio icon to get information about stocks you own without leaving the research pagefaster access to positions a shortcut to view the full list of positions in your portfolio yes please use the ticker search boxadd your own notes use notebook to save your investment ideas in one convenient private and secure place convenient for youresearch thats clear accessible and all in one place makes for a better experienceonestop shop see everything you need to make investment decisions right in the dashboardaccess anywhere no matter where you are use the stock research experience across multiple devicesnew ideas on the ready find new ideas using quick links to the stock screener new ways to researchdiscover new tools to add or diversify your existing research strategystocktwits read live tweets from the financial and investing community about the stock youre interested infundamental analysis save time on research by getting an overall assessment of a companys valuation quality growth stability and financial healthrecognia technical analysis perfect for the technical trader—this indicator captures a stocks technical events and converts them into short medium and longterm sentimenttop competitors see how a stock measures up by instantly comparing it to the industry average and its top four competitorssocial sentiment get a sense of peoples overall feelings towards a company in social media with this summary toolearnings data monitor earnings expectations over the past three quarters and model a stocks price based on its pe schumacher the schumacher bulletin is a mustread for everyone in the design industry subscribe now forgot password sign in web access current schumacher trade account holders are invited to register for web access as a schumacher account holder with web access you can use the following online tools • view your shopping bag and place orders • check stock availability • check your order status • download helpful files sign up for web access trade account since  schumachers exquisite products have helped design professionals create exclusive and luxurious interiors if you are a member of the design trade interested in establishing an account with schumacher please click on the register button below all applications are subject to review and approval by schumacher apply for a trade account new arrivals indoor  outdoor perfect basics lookbooks collections shop fabrics new arrivals lookbooks collections shop wallpaper new arrivals collections shop trim shop furniture a leading source of luxury floor coverings patterson flynn martins offerings include exclusive tibetan wilton handtufted and handknotted rugs and the ability to fulfill all of the custom wishes of even the most discerning clients visit patterson flynn martin make it your own schumacher is the premier source of luxury fabrics wallcoverings and trim for the contract market custom residential projects and historic reproductions to learn more please call us at  learn more weve got you covered got a big presentation need samples want custom colors have contract code requirements whatever is on your drawing board when it comes to tools of the trade schumacher is a designer’s best resource learn more new arrivals indoor  outdoor perfect basics lookbooks collections shop fabrics new arrivals lookbooks collections shop wallpaper new arrivals collections shop trim shop furniture a leading source of luxury floor coverings patterson flynn martins offerings include exclusive tibetan wilton handtufted and handknotted rugs and the ability to fulfill all of the custom wishes of even the most discerning clients visit patterson flynn martin make it your own schumacher is the premier source of luxury fabrics wallcoverings and trim for the contract market custom residential projects and historic reproductions to learn more please call us at  learn more weve got you covered got a big presentation need samples want custom colors have contract code requirements whatever is on your drawing board when it comes to tools of the trade schumacher is a designer’s best resource learn more new arrivals fabric wallpaper trim furniture rugs  carpets custom  contract services get to know us blog new arrivals fabric wallpaper trim furniture rugs  carpets custom  contract services get to know us blog my orders my profile my favorites downloads sign out my orders my profile my favorites downloads sign out my orders my profile my favorites downloads sign out search anytime by typing sign in to my schumacher forgot password sign in web access current schumacher trade account holders are invited to register for web access as a schumacher account holder with web access you can use the following online tools view your shopping bag and place orders check stock availability check your order status download helpful files sign up for web access trade account since  schumachers exquisite products have helped design professionals create exclusive and luxurious interiors if you are a member of the design trade interested in establishing an account with schumacher please click on the register button below all applications are subject to review and approval by schumacher apply for a trade account shop the world of schumacher dont miss a beat customer care contact faq find a designer returns  exchanges glossary of terms follow us download our app   careers if you are passionate about design and interested in contributing to our tradition of excellence then click here to find out more careers if you are passionate about design and interested in contributing to our tradition of excellence then click here to find out more sign up for our newsletter sign up terms of use privacy policy site map   schumacher and co